Literature DB >> 17646900

Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.

Aydin Ece1, Selvi Kelekçi, Halil Kocamaz, Aşkin Hekimoğlu, Hasan Balik, Ilyas Yolbaş, Ozcan Erel.   

Abstract

The aim of this study was to assess the role of oxidative stress in the pathogenesis of Henoch-Schönlein purpura (HSP) vasculitis. The activities of catalase (CAT), arylesterase (ARYL), and paraoxonase (PON) as antioxidant enzymes and serum malondialdehyde (MDA) level as an indicator of lipid peroxidation, together with total antioxidant status (TAS), were measured in 29 children with HSP (mean age 9.3 +/- 2.7 years), both at the onset of the disease and at the remission period and in matched controls. Active-stage HSP had significantly higher MDA level (15.5 +/- 7.3 vs 7.8 +/- 3.9 nmol/l, respectively, P < 0.001) and lower TAS (524 +/- 122 vs 699 +/- 122 mumol Trolox Equiv/l, P < 0.001), PON (97 +/- 47 vs 136 +/- 95 U/l, P = 0.042), ARYL (158 +/- 39 vs 212 +/- 52 U/l, P < 0.001), and CAT (50 +/- 27 vs 69 +/- 20 U/l, P = 0.002) activities compared with the control subjects. Although CAT (P > 0.05) and PON (P > 0.05) activities were found to be similar between active and remission stages of HSP, the active stage of the disease had significantly lower ARYL (P = 0.011) and TAS (P = 0.006) and higher MDA (P < 0.001) values compared with remission period. Significant positive correlations were found between CAT and MDA (r = 0.433, P = 0.019) and between CAT and C-reactive protein (r = 0.386, P = 0.035) in the active stage of HSP. No significant differences were detected in oxidant/antioxidant parameters between patients with or without renal, gastrointestinal, or joint involvement (P > 0.05). Increased oxidative stress and lipid peroxidation may play important roles in the pathogenesis of HSP vasculitis. Antioxidant therapeutic interventions in long-lasting vasculitis and risk of atherosclerosis secondary to increased oxidant stress remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646900     DOI: 10.1007/s10067-007-0671-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.

Authors:  L Haagen; A Brock
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-07

Review 2.  Oxidative stress, antioxidants, and vascular damage.

Authors:  Pietro Minuz; Cristiano Fava; Luciano Cominacini
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

3.  Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors.

Authors:  F Nielsen; B B Mikkelsen; J B Nielsen; H R Andersen; P Grandjean
Journal:  Clin Chem       Date:  1997-07       Impact factor: 8.327

4.  Total antioxidant status in plasma and body fluids.

Authors:  C Rice-Evans; N J Miller
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 5.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

6.  Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch Schönlein purpura.

Authors:  G Demircin; A Oner; Y Unver; M Bülbül; O Erdoğan
Journal:  Acta Paediatr       Date:  1998-08       Impact factor: 2.299

7.  Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils.

Authors:  L Harper; S L Nuttall; U Martin; C O S Savage
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

Review 8.  Human disease, free radicals, and the oxidant/antioxidant balance.

Authors:  J M McCord
Journal:  Clin Biochem       Date:  1993-10       Impact factor: 3.281

9.  Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura.

Authors:  O Erdoğan; A Oner; A Aydin; A Işimer; G Demircin; M Bülbül
Journal:  Acta Paediatr       Date:  2003-05       Impact factor: 2.299

10.  Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats.

Authors:  S V Shah
Journal:  Am J Physiol       Date:  1988-03
View more
  8 in total

1.  Elevated serum xanthine oxidase activities in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-hong Zhang; Ying Gao
Journal:  Clin Rheumatol       Date:  2009-08-23       Impact factor: 2.980

2.  The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson's disease.

Authors:  Gülser Karadaban Emir; Yasemin Ünal; Nigar Yılmaz; Kürsad Tosun; Gülnihal Kutlu
Journal:  Neurol Sci       Date:  2019-07-06       Impact factor: 3.307

3.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

Review 4.  Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy.

Authors:  Aleksandra Musiała; Piotr Donizy; Hanna Augustyniak-Bartosik; Katarzyna Jakuszko; Mirosław Banasik; Katarzyna Kościelska-Kasprzak; Magdalena Krajewska; Dorota Kamińska
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

5.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

Review 6.  Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.

Authors:  Crislaine Aparecida da Silva; Mariana Molinar Mauad Cintra; Eliângela de Castro Côbo; Marcos Vinícius da Silva; Fabiano Bichuette Custódio; Rosana Rosa Miranda Corrêa; Lúcio Roberto Castellano; Marlene Antônia dos Reis; Juliana Reis Machado
Journal:  Dis Markers       Date:  2014-02-25       Impact factor: 3.434

7.  Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura.

Authors:  Dolunay Gurses; Nusret Parlaz; Melek Bor-Kucukatay; Vural Kucukatay; Gulten Erken
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

8.  Association between red blood cell distribution width and Henoch-Schonlein purpura nephritis.

Authors:  Hui Xu; Wei Li; Jian-Hua Mao; Yan-Xiang Pan
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.